This Government Contract opportunity from Department Of Health And Human Services was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Phase I Clinical Trial Management and Execution
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract focuses on the design, management, and execution of Phase I clinical trials specifically for biodosimetric tools or medical countermeasures (MCMs). Key responsibilities include developing the clinical trial protocols and conducting safety monitoring throughout the trial process. This subcontract is associated with the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services and falls under the NAICS code 541611, which pertains to administrative management and general management consulting services. The contract was posted on May 18, 2026, with a response deadline of June 2, 2026, indicating a relatively short turnaround time for proposals. There is no specified set-aside type or specific organizational restrictions noted. The place of performance and point of contact details are not provided, suggesting potential flexibility or that these details will be determined after the contract award. The scope emphasizes early-phase clinical trials with a strong regulatory and safety oversight component, essential for advancing biodosimetric tools or MCMs toward further development and eventual approval.
General Info
Agency
NAICS
Place of Performance
MD, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
